Buy, Sell or Hold: Rigel Pharmaceuticals (RIGL-Q) — Stock Predictions at Stockchase

NASDAQ:RIGL

2.77

0.15 (5.14%) 1d

Showing 1 to 1 of 1 entries

DON'T BUY

It has a lot of inflammatory, auto-immune competition. Spec stocks in this business, he can't recommend.

Pharma & Healthcare

Showing 1 to 1 of 1 entries

Rigel Pharmaceuticals(RIGL-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Rigel Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Rigel Pharmaceuticals(RIGL-Q) Frequently Asked Questions

What is Rigel Pharmaceuticals stock symbol?

Rigel Pharmaceuticals is a American stock, trading under the symbol RIGL-Q on the NASDAQ (RIGL). It is usually referred to as NASDAQ:RIGL or RIGL-Q

Is Rigel Pharmaceuticals a buy or a sell?

In the last year, 1 stock analyst published opinions about RIGL-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Rigel Pharmaceuticals.

Is Rigel Pharmaceuticals a good investment or a top pick?

Rigel Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Rigel Pharmaceuticals.

Why is Rigel Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Rigel Pharmaceuticals worth watching?

In the last year, there was no coverage of Rigel Pharmaceuticals published on Stockchase.

What is Rigel Pharmaceuticals stock price?

On 2021-11-26, Rigel Pharmaceuticals (RIGL-Q) stock closed at a price of $2.77.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.